PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2563941-3	1989	The hormonal response to corticotropin-releasing factor (10(-10) mol/l), vasopressin (10(-9) mol/l) as well as KC1 (48 mmol/l) was reduced by membrane permeant analogs of cGMP, such as 8-BrcGMP and dibutyryl-cGMP.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	185-193	arginine vasopressin	Rattus norvegicus	73-84	
2563941-4	1989	The 8-BrcGMP analog (10(-5) mol/l) inhibited corticotropin release in response to corticotropin-releasing factor by 30%, that to vasopressin by 70%, and that to KCl by 50%.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	4-12	arginine vasopressin	Rattus norvegicus	129-140	
10375810-3	1998	RESULTS: Both 8-Br-cGMP 2.53 g.L-1 and L-arginine 100 g.L-1 increased plasma AVP level [from (2.6 +/- 0.3) to (6.6 +/- 0.4) ng.L-1, and from (3.2 +/- 0.5) to (5.8 +/- 1.4) ng.L-1, respectively; P < 0.01] 5 min after the icv injection; methylene blue (3.74 g.L-1) + L-arginine (100 g.L-1) did not change plasma AVP level.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	14-23	arginine vasopressin	Rattus norvegicus	77-80	
10375810-3	1998	RESULTS: Both 8-Br-cGMP 2.53 g.L-1 and L-arginine 100 g.L-1 increased plasma AVP level [from (2.6 +/- 0.3) to (6.6 +/- 0.4) ng.L-1, and from (3.2 +/- 0.5) to (5.8 +/- 1.4) ng.L-1, respectively; P < 0.01] 5 min after the icv injection; methylene blue (3.74 g.L-1) + L-arginine (100 g.L-1) did not change plasma AVP level.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	14-23	arginine vasopressin	Rattus norvegicus	313-316